From: Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
Cancer type
Mutation/tumor
Respiratory/lung cancer
200–300
Skin/melanoma
100–200
Esophageal/colon cancer
50–100
Pancreatic, ovarian
30–60
Breast
20–70
Hematopoietic cancer
1–10
(CML/AML/ALL/CLL) rhabdo/myo/sarcoma
1–3